Published in Liver Transpl on March 01, 2006
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation. World J Surg (2009) 3.47
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology (2005) 1.82
Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl (2004) 1.66
Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl (2003) 1.61
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl (2007) 1.54
Elimination of indocyanine green in the perioperative evaluation of donor liver function. Anesth Analg (2002) 1.53
Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation (2003) 1.46
Herpes simplex in a liver transplant recipient. Liver Transpl (2006) 1.39
Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol (2008) 1.31
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl (2003) 1.31
Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl (2008) 1.19
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl (2008) 1.18
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18
The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl (2006) 1.03
Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis (2007) 0.96
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. J Clin Endocrinol Metab (2011) 0.95
Breast cancer in Western Australia: clinical practice and clinical guidelines. Med J Aust (2004) 0.94
Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer (2010) 0.94
Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant (2004) 0.90
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol (2013) 0.90
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation (2003) 0.89
Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation (2013) 0.89
Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer (2012) 0.86
Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int (2007) 0.86
Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl (2008) 0.85
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl (2003) 0.85
Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest (2009) 0.83
Malpositioned transjugular intrahepatic portosystemic shunt in the common hepatic duct leading to biliary obstruction and liver transplantation. Liver Transpl (2011) 0.83
Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg (2008) 0.82
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl (2013) 0.81
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl (2008) 0.80
Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant (2013) 0.80
Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Liver Transpl (2002) 0.80
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601. ANZ J Surg (2007) 0.79
Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases. Transplantation (2008) 0.79
Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma. Expert Opin Pharmacother (2007) 0.78
Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation (2009) 0.78
Risk factors associated with acute heart failure during liver transplant surgery: a case control study. Transplantation (2015) 0.76
The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clin Transplant (2010) 0.76
Role of adult living donor liver transplantation in patients with hepatitis C. Liver Transpl (2003) 0.76
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl (2014) 0.75
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity. Clin Transplant (2013) 0.75
The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anesth (2012) 0.75
Kayser-Fleischer rings of acute Wilson's disease. Proc (Bayl Univ Med Cent) (2013) 0.75
An evidence-based specialist breast nurse role in practice: a multicentre implementation study. Eur J Cancer Care (Engl) (2003) 0.75
Structure-reactivity correlations for solid-state enantioselective photochemical reactions established directly from powder X-ray diffraction. J Am Chem Soc (2006) 0.75
Hepatic artery pseudoaneurysm - duodenal fistula after living donor liver transplant. Clin Transplant (2004) 0.75